20 Aug arrest of 'Wanathe Chathu' puts UAE pharmacy controls back in view

Hiru News reported on 20 August 2026 that an alleged organised crime figure and drug trafficker known as 'Wanathe Chathu' was arrested in Dubai, a case that gives UAE pharmacy operators a fresh reason to test controlled-medicine compliance before a regulator asks for the records.

The highest-stakes readers are COOs, pharmacy directors and insurers. For clinics and pharmacies, the issue is chain-of-custody discipline. For payers, including Daman, Thiqa and Sukoon where their policies cover dispensed medicines, the issue is whether claims and prior approvals separate legitimate controlled prescriptions from irregular dispensing. For patients, the practical risk is simpler: a legal prescription abroad can still require UAE documentation before possession or dispensing.

What is known about the arrest

The Hiru News report said the arrest involved an alleged organised crime gang member and drug trafficker known as 'Wanathe Chathu'. Other Sri Lankan outlets identified him as Avishka Madhushan Abeygunawardena, but UAE authorities had not published a named health-sector notice on the case at the time of writing.

That distinction matters for UAE healthcare operators. This is a criminal-law story first, not a pharmacy enforcement action. The healthcare relevance is the compliance perimeter around narcotic, psychotropic and semi-controlled medicines in Dubai, Abu Dhabi and the northern emirates.

The UAE Government portal says Federal Decree-Law No. 30 of 2021 criminalises the production, import, export, transport, purchase, sale, possession and storage of narcotic and psychotropic substances unless authorised by law. The same portal describes the UAE position on recreational drug use as zero tolerance.

What pharmacies and clinics should check

In Dubai, the relevant health regulator is the Dubai Health Authority (DHA). DHA's drug-control service is the channel for doctors and pharmacists to register, prescribe and dispense narcotic and controlled or semi-controlled medicines through an electronic system. In Abu Dhabi and Al Ain, the regulator is the Department of Health Abu Dhabi (DOH). In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, the relevant health regulator is the Ministry of Health and Prevention (MOHAP).

Operators should treat the arrest as a prompt for a file-level review, not as evidence that licensed providers were involved. A practical review can be done inside 10 working days by sampling the most recent narcotic and psychotropic transactions and matching prescription, prescriber licence, patient identifier, dispensing record, stock movement and insurer approval where applicable.

• DHA facilities: confirm access rights, active prescriber IDs and pharmacist credentials in the drug-control workflow.
• DOH facilities: check controlled-medicine storage against DOH requirements, including locked cabinets, restricted access and CCTV coverage for secure areas.
• MOHAP-licensed facilities: verify import, storage and dispensing permissions before stocking any medicine on controlled schedules.
• Insurers and TPAs: flag duplicate controlled-medicine claims, cash conversions after rejected claims and early refill patterns for pharmacy audit.

The DOH standard for narcotics, psychotropics and semi-controlled medicinal products states that semi-controlled prescriptions are valid for no more than three days from the date of issue. It also requires narcotic registers and prescription forms to be held in secure cabinets, with medicines stored in approved pharmacy or medication-room settings.

Patient risk is a documentation problem

Patients should not rely on informal advice from a pharmacy counter, airline desk or social-media group. The UAE Government portal directs travellers carrying controlled medication into the UAE to obtain approval through MOHAP before travel. A valid prescription from another country is useful evidence, but it is not the whole UAE compliance file.

For clinics, this creates a front-desk and call-centre task. Patients asking about ADHD medication, opioid pain medicine, benzodiazepines or other controlled therapies should be routed to a licensed clinician or pharmacist before they bring medicines into the UAE or request refills. If the medicine is covered by insurance, the patient should also be told to check the payer's formulary and prior-authorisation rules before dispensing.

Prices should not be guessed. For Abu Dhabi claims and reimbursement checks, finance teams can use the DOH Shafafiya dictionary and the reference price list updated on 21 January 2025. For Dubai and northern-emirate patients, pharmacy teams should verify the product, pack size and payer network directly with the licensed pharmacy and insurer before quoting an AED amount.

The next step for operators is operational rather than public-relations driven: confirm the responsible pharmacist, test controlled-drug logs, and document how suspicious requests are escalated. Patients looking for legitimate dispensing options should use the UAE Open Healthcare Directory to find licensed pharmacy providers by emirate, regulator and insurance network.